Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lignocaine versus lignocaine + hyoscine butylbromide for pain reduction during manual vacuum aspiration
PACTR202409853980242Phase 0Recruiting
- Sponsor
- Federal Government of Nigeria
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of lidocaine and hyoscine butylbromide in Incomplete Abortion (IA) (2 arms), sponsored by Federal Government of Nigeria. Primary endpoint: Reduction in intraprocedural pain scores. Started Jun 2024; status: recruiting.
02
Drugs
lidocainehyoscine butylbromide
03
Conditions
Incomplete Abortion (IA)
Beyond the preview
Go deeper on PACTR202409853980242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409853980242.